Search Results - "Pieper, J A"

Refine Results
  1. 1

    Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers by Williamson, Kristin M., Patterson, J. Herbert, McQueen, Robert H., Adams, Kirkwood F., Pieper, John A.

    Published in Clinical pharmacology and therapeutics (01-03-1998)
    “…Background Losartan is metabolized by CYP2C9 and CYP3A4 to an active metabolite, E3174, which has greater antihypertensive activity than the parent compound…”
    Get full text
    Journal Article
  2. 2

    Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan by McCune, Jeannine S., Lindley, Celeste, Decker, Jodi L., Williamson, Kristin M., Meadowcroft, Amy M., Graff, Donald, Sawyer, William T., Blough, David K., Pieper, John A.

    Published in Journal of clinical pharmacology (01-07-2001)
    “…Gender‐based differences in cytochrome P450 (CYP) activity may occur due to endogenous hormonal fluctuations with the menstrual cycle, which are altered by…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Management of Coronary Heart Disease Risk Factors and Progression with Calcium Channel Blockers by Pieper, John A.

    Published in Pharmacotherapy (01-09-2001)
    “…The death rate from coronary heart disease (CHD) declined by 25% in the United States during 1987–1997, but the actual number of deaths fell by only 9%…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    The Effects of Fluvastatin, a CYP2C9 Inhibitor, on Losartan Pharmacokinetics in Healthy Volunteers by Meadowcroft, Amy M., Williamson, Kristin M., Patterson, J. Herbert, Hinderliter, Alan L., Pieper, John A.

    Published in Journal of clinical pharmacology (01-04-1999)
    “…Losartan is an angiotensin II receptor antagonist that is metabolized by CYP2C9 and CYP3A4 to a more potent antihypertensive metabolite, E3174. Interaction…”
    Get full text
    Journal Article
  6. 6

    Clinical pharmacokinetics of fluvastatin by SCRIPTURE, Charity D, PIEPER, John A

    Published in Clinical pharmacokinetics (2001)
    “…Fluvastatin, the first fully synthetic HMG-CoA reductase inhibitor, has been shown to reduce cholesterol in patients with hyperlipidaemia, to prevent…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhaled verapamil-induced bronchoconstriction in mild asthma by Harman, E, Hill, M, Pieper, J A, Hendeles, L

    Published in Chest (01-07-1991)
    “…Methacholine challenges were performed in ten subjects with mild asthma at 2 h before and 20 min after placebo or 5, 10, 20, 40, 80, and 160 mg of inhaled…”
    Get more information
    Journal Article
  9. 9

    Altered protein binding of etoposide in patients with cancer by Stewart, C F, Pieper, J A, Arbuck, S G, Evans, W E

    Published in Clinical pharmacology and therapeutics (01-01-1989)
    “…Etoposide plasma protein binding (PB) is reported to be 94% based on in vitro studies using normal human serum albumin (SA). Etoposide PB in 17 patients with…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Effects of chronic phenobarbital on verapamil disposition in humans by Rutledge, D R, Pieper, J A, Mirvis, D M

    “…Very little is known about the effects of hepatic enzyme induction with phenobarbital on the disposition of high clearance drugs in humans. Our study was…”
    Get more information
    Journal Article
  12. 12

    Optimal Management of Amiodarone Therapy: Efficacy and Side Effects by Hilleman, Daniel, Miller, Mary Ann, Parker, Robert, Doering, Paul, Pieper, John A.

    Published in Pharmacotherapy (01-11-1998)
    “…Objectives. To review management and dosing guidelines for amiodarone therapy, and discuss the drug's adverse event profile. Methods. Review of relevant…”
    Get full text
    Journal Article
  13. 13

    Gallopamil binding to human serum proteins by RUTLEDGE, D. R, PIEPER, J. A

    Published in European journal of clinical pharmacology (01-01-1987)
    “…We have determined the extent and variability in the binding of gallopamil to human serum proteins. Binding was determined by equilibrium dialysis in healthy…”
    Get full text
    Journal Article
  14. 14

    Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state by LALONDE, R. L, PIEPER, J. A, STRAKA, R. J, BOTTORFF, M. B, MIRVIS, D. M

    Published in European journal of clinical pharmacology (01-01-1987)
    “…The duration and extent of cardiac beta-blockade and their relationship to propranolol pharmacokinetics were assessed in nine healthy volunteers. Each subject…”
    Get full text
    Journal Article
  15. 15

    Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum by Straka, R J, Hoon, T J, Lalonde, R L, Pieper, J A, Bottorff, M B

    Published in Clinical chemistry (Baltimore, Md.) (01-10-1987)
    “…We analyzed 99 patients' serum samples for concentrations of a new antiarrhythmic agent, flecainide acetate, by fluorescence polarization immunoassay (FPIA)…”
    Get more information
    Journal Article
  16. 16

    Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome by Phelps, S J, Alpert, B S, Ward, J L, Pieper, J A, Lima, J J

    Published in Journal of clinical pharmacology (01-03-1995)
    “…The negative inotropic and chronotropic effects of beta-blocker therapy have been reported to reduce morbidity and mortality in patients with Marfan syndrome;…”
    Get more information
    Journal Article
  17. 17

    Hepatic drug clearance in children: studies with indocyanine green as a model substrate by Evans, W E, Relling, M V, de Graaf, S, Rodman, J H, Pieper, J A, Christensen, M L, Crom, W R

    Published in Journal of pharmaceutical sciences (01-06-1989)
    “…For several drugs metabolized by the liver, higher dosages (mg/kg body weight) are required in children to attain serum concentrations comparable to those in…”
    Get more information
    Journal Article
  18. 18

    Determination of verapamil and its primary metabolites in serum by ion-pair adsorption high-performance liquid chromatography by Pieper, J A, Rutledge, D R

    Published in Journal of chromatographic science (01-09-1988)
    “…A high-performance liquid chromatographic (HPLC) method for the simultaneous quantitation of verapamil, norverapamil, N-dealkylverapamil (D617) and…”
    Get more information
    Journal Article
  19. 19

    Lorazepam pharmacodynamics and pharmacokinetics in children by Relling, M V, Mulhern, R K, Dodge, R K, Johnson, D, Pieper, J A, Rivera, G K, Evans, W E

    Published in The Journal of pediatrics (01-04-1989)
    “…We evaluated the effects of low doses of lorazepam on episodic versus long-term memory, attention, and somatic and affective symptoms, as well as its…”
    Get more information
    Journal Article
  20. 20

    The effect of ranitidine and cimetidine on imipramine disposition by WELLS, B. G, PIEPER, J. A, SELF, T. H, STEWART, C. F, WALDON, S. L, BOBO, L, WARNER, C

    Published in European journal of clinical pharmacology (01-01-1986)
    “…The pharmacokinetic characteristics of imipramine were studied after a single, oral, 100 mg dose was taken by 12 healthy male subjects following 3 days of…”
    Get full text
    Journal Article